These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30393022)

  • 1. Human placenta-derived mesenchymal stem cells ameliorate GVHD by modulating Th17/Tr1 balance via expression of PD-L2.
    Ma Y; Wang Z; Zhang A; Xu F; Zhao N; Xue J; Zhang H; Luan X
    Life Sci; 2018 Dec; 214():98-105. PubMed ID: 30393022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-27 Promotes Human Placenta-Derived Mesenchymal Stromal Cell Ability To Induce the Generation of CD4
    Yi J; Chen Z; Xu F; Wang Z; Zhang A; Liu T; Zhao N; Xiong Y; Jiang G; Ma J; Luan X
    J Immunol; 2019 Feb; 202(4):1124-1136. PubMed ID: 30651340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4
    Zhang A; Xiong Y; Xu F; Wang Z; Ma J; Zhao N; Hu T; Yi J; Zhou Y; Luan X
    Cell Immunol; 2020 Jun; 352():104113. PubMed ID: 32331794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hPMSCs inhibit the expression of PD-1 in CD4
    Zhang A; Zhang J; Li X; Zhang H; Xiong Y; Wang Z; Zhao N; Wang F; Luan X
    Stem Cell Res Ther; 2021 Jun; 12(1):368. PubMed ID: 34187557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human placental mesenchymal stromal cells promote the formation of CD8
    Zhao Y; Chen Z; Wu Y; Zhang J; Zhang H; Han K; Wang H; Li H; Luan X
    Int Immunopharmacol; 2024 Sep; 138():112554. PubMed ID: 38968861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placenta derived mesenchymal stromal cells alleviate GVHD by promoting the generation of GSH and GST in PD-1
    Zhuoya W; Nannan Z; Aiping Z; Guoyan W; Menghua D; Jiashen Z; Yanlian X; Xiying L
    Cell Immunol; 2020 Jun; 352():104083. PubMed ID: 32143837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PD-L1/PD-L2 on human placenta-derived mesenchymal stem cells inhibits the IL-17 secretion of peripheral blood T cells].
    Wang G; Wang F; Li H; Zhang L; Luan X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):132-6. PubMed ID: 23388330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta‑derived mesenchymal stem cells improve airway hyperresponsiveness and inflammation in asthmatic rats by modulating the Th17/Treg balance.
    Li Y; Li H; Cao Y; Wu F; Ma W; Wang Y; Sun S
    Mol Med Rep; 2017 Dec; 16(6):8137-8145. PubMed ID: 28944907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
    Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
    Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IFN-γ up-regulates PD-L1 expression in human placenta mesenchymal stem cells and enhances cell ability to induce the differentiation of IL-10+ T cells from cord blood- and peripheral blood-derived T cells].
    Wang W; Li H; Xu F; DU H; Li X; Yi J; Wang G; Luan X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):191-5. PubMed ID: 26927379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hPMSCs prevent erythrocytes dysfunction caused by graft versus host disease via promoting GSH synthesis.
    Xiong Y; Wang F; Mu H; Zhang A; Zhao Y; Han K; Zhang J; Zhang H; Wang Z; Ma J; Wei R; Luan X
    Int Immunopharmacol; 2024 Sep; 139():112689. PubMed ID: 39029234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
    Park M; Banga JP; Kim GJ; Kim M; Lew H
    Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transplantation of human placenta mesenchymal stem cells reduces the level of inflammatory factors in lung tissues of mice with acute lung injury].
    Xu M; Liu G; Jia Y; Yan X; Ma X; Wei J; Liu X; Ma X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):105-109. PubMed ID: 29673451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hPMSCs Regulate the Level of TNF-α and IL-10 in Th1 Cells and Improve Hepatic Injury in a GVHD Mouse Model via CD73/ADO/Fyn/Nrf2 Axis.
    Zhang H; Han K; Li H; Zhang J; Zhao Y; Wu Y; Wang B; Ma J; Luan X
    Inflammation; 2024 Feb; 47(1):244-263. PubMed ID: 37833615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring Ovarian Function With Human Placenta-Derived Mesenchymal Stem Cells in Autoimmune-Induced Premature Ovarian Failure Mice Mediated by Treg Cells and Associated Cytokines.
    Yin N; Zhao W; Luo Q; Yuan W; Luan X; Zhang H
    Reprod Sci; 2018 Jul; 25(7):1073-1082. PubMed ID: 28954601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
    Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
    J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation.
    Tago Y; Kobayashi C; Ogura M; Wada J; Yamaguchi S; Yamaguchi T; Hayashi M; Nakaishi T; Kubo H; Ueda Y
    Sci Rep; 2021 Jan; 11(1):2406. PubMed ID: 33510297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.